Gainers
- ShiftPixy, Inc. PIXY jumped 33.1% to settle at $3.34 on Thursday as the company said it has been named as sponsor related to 4 SPACs.
- Takung Art Co., Ltd. TKAT surged 24.2% to close at $39.11
- JAKKS Pacific, Inc. JAKK gained 23.4% to close at $9.05 after the company reported better-than-expected Q1 results.
- Galera Therapeutics, Inc. GRTX climbed 22.8% to settle at $8.12 after the company announced updated results from its Phase 1/2 pilot trial of GC4419, versus placebo, in patients with locally advanced pancreatic cancer who are undergoing stereotactic body radiation therapy.
- Ocular Therapeutix, Inc. OCUL gained 22.7% to close at $19.16. Ocular Therapeutix, reported multiple scientific presentations at the Association for Research in Vision and Ophthalmology Annual Meeting.
- 1-800-FLOWERS.COM, Inc. FLWS jumped 20.5% to close at $29.89 after the company reported better-than-expected Q3 results.
- Willamette Valley Vineyards, Inc. WVVI gained 19.6% to close at $12.25 on Thursday.
- SkyWater Technology, Inc. SKYT rose 16.9% to close at $21.77. The company, last week, priced its IPO at $14 per share.
- VEREIT, Inc. VER jumped 16% to close at $47.88 after the company announced an all-stock merger agreement with Realty Income.
- MEDIROM Healthcare Technologies Inc. MRM gained 15.2% to close at $10.31.
- Sharps Compliance Corp. SMED surged 15% to close at $18.41 on continued upward momentum after the company reported better-than-expected Q3 EPS and sales results. Following earnings, HC Wainwright & Co maintained a Buy and raised its price target from $18 to $25.
- Capricor Therapeutics, Inc. CAPR shares jumped 14.9% to close at $4.54 after the company signed exclusive worldwide license agreement with Johns Hopkins University to include engineered exosomes for vaccines and therapeutics as part of the company's exosome technology portfolio.
- Communications Systems, Inc. JCS gained 14.5% to close at $6.73 as the company agreed to sell its Transition Networks and Net2Edge businesses to Lantronix.
- Enlivex Therapeutics Ltd. ENLV surged 14.2% to settle at $12.10.
- Dolphin Entertainment, Inc. DLPN shares rose 13.2% to close at $12.99. Dolphin Entertainment recently reported better-than-expected Q4 sales results.
- Century Communities, Inc. CCS gained 13.1% to settle at $74.94 after the company reported better-than-expected Q1 EPS and sales results. The company also raised its FY21 sales guidance.
- GreenBox POS GBOX surged 13.1% to close at $11.35.
- North American Construction Group Ltd. NOA gained 12.5% to close at $13.28 after the company reported Q1 earnings results.
- Extreme Networks, Inc. EXTR climbed 12.4% to close at $12.01. The company recently reported better-than-expected Q3 results.
- Summer Infant, Inc. SUMR gained 12% to settle at $18.91.
- Nokia Corporation NOK shares jumped 11.2% to close at $4.67 after reporting upbeat Q1 results.
- Realogy Holdings Corp. RLGY climbed 10.4% to close at $16.83 following upbeat quarterly results.
- Alliance Data Systems Corporation ADS jumped 10% to close at $118.64 following upbeat Q1 results.
- Vaxart, Inc. VXRT climbed 9.1% to settle at $9.21 as the company said its founder and chief scientific officer, Sean Tucker, Ph.D., will present at the World Vaccine Congress Washington that will be held virtually from May 4-6, 2021.
- Bloomin' Brands, Inc. BLMN rose 8.9% to settle at $31.38 after the company reported better-than-expected Q1 results.
- MRC Global Inc. MRC surged 8.9% to close at $9.87. The company recently released Q1 results.
- AtriCure, Inc. ATRC gained 8.8% to close at $76.00 after the company reported that its EPi-Sense System was approved by the FDA for treatment of long-standing persistent afib patients.
- Facebook, Inc. FB rose 7.3% to close at $329.51 after the company reported upbeat results for its first quarter on Wednesday. The company reported 1.88 billion daily active users, up 8% year-over-year, as well as 2.85 billion monthly active users, up 10% year-over-year.
- Cheesecake Factory Inc CAKE rose 7.1% to settle at $63.20 after reporting higher quarterly earnings.
- QUALCOMM Incorporated QCOM rose 4.5% to close at $142.68 after the company reported better-than-expected Q2 results and issued strong Q3 EPS guidance.
Check out these big penny stock gainers and losers
Losers
- Adverum Biotechnologies, Inc. ADVM shares tumbled 62.3% to close at $3.83 on Thursday after the company announced a suspected unexpected serious adverse reaction of hypotony, which is clinically relevant decrease in ocular pressure, in its INFINITY clinical trial evaluating ADVM-022 gene therapy for the treatment of diabetic macular edema.
- Farmmi, Inc. FAMI fell 54.7% to close at $0.3580 after the company priced its $42.0 million upsized underwritten public offering of ordinary shares.
- Cara Therapeutics, Inc. CARA dropped 45.4% to close at $14.07 after the company announced mixed topline results from its KARE Phase 2 dose-ranging clinical trial of oral Korsuva for the treatment of moderate-to-severe pruritus in mild-to-severe atopic dermatitis patients. The company said the study did not meet the primary endpoint of worst-itch NRS change from baseline at week 12 or secondary endpoint of 4-point responder analysis in the intent-to-treat patient population. However, the study achieved primary endpoint of worst-itch NRS change and secondary endpoint of 4-point responder analysis in pre-specified analyses of mild-to-moderate AD patients, comprising 64% of ITT population.
- Atomera Incorporated ATOM fell 24.8% to close at $16.68 after the company reported Q1 earnings results.
- Palisade Bio, Inc. PALI fell 23.9% to close at $7.80.
- Brooklyn ImmunoTherapeutics, Inc. BTX dipped 21.8% to close at $34.22. Brooklyn ImmunoTherapeutics acquired license for mRNA technology platform of Factor Bioscience Limited And Novellus Therapeutics Limited.
- Brightcove Inc. BCOV dipped 20% to settle at $15.56 after the company issued Q2 EPS and sales guidance below estimates.
- Tiptree Inc. TIPT fell 19.5% to close at $10.10 after the company reported it has decided to withdraw the registration statement relating to previously announced IPO by Fortegra due to ‘prevailing market conditions and the high value.’
- Impinj, Inc. PI dropped 19.4% to settle at $46.81 after reporting a decline in quarterly earnings.
- Vyant Bio, Inc. VYNT fell 19.1% to close at $3.76 after climbing 16% on Wednesday. Vyant Bio, Ordaōs Bio and Cellaria, recently announced collaboration to 'design and qualify biomarker-specific small protein therapeutics.'
- Selecta Biosciences, Inc. SELB dipped 19% to close at $3.15. Based on an internal strategic review and prioritization of its portfolio, Asklepios BioPharmaceutical Inc (AskBio) has decided to give all rights of methylmalonic acidemia (MMA) to Selecta Biosciences.
- FormFactor, Inc. FORM fell 18.2% to close at $39.22 after the company reported worse-than-expected Q1 EPS results.
- Regional Health Properties, Inc. RHE dropped 17.9% to close at $5.23.
- Galectin Therapeutics Inc. GALT shares fell 16.9% to settle at $4.24 after jumping over 22% on Wednesday. The company recently announced neurosurgeon Dr. Ben Carson, Sr. joined the team as a special consultant to accelerate and enhance development of the company's galectin-3 inhibitor, belapectin.
- Cohu, Inc. COHU dipped 16.9% to close at $38.85 after reporting Q1 results.
- 22nd Century Group, Inc. XXII fell 15.7% to settle at $4.74.
- Resolute Forest Products Inc. RFP fell 15.4% to close at $13.17 after reporting preliminary Q1 results.
- Coeur Mining, Inc. CDE dropped 14.4% to settle at $8.23 after the company reported worse-than-expected Q1 EPS and sales results.
- Aurora Mobile Limited JG fell 14.3% to close at $3.61.
- MicroVision, Inc. MVIS dipped 14.2% to close at $18.00.
- Aspen Technology, Inc. AZPN fell 13.2% to settle at $132.64 after the company reported worse-than-expected Q3 EPS and sales results. The company also issued FY21 EPS and sales guidance below analyst estimates.
- Cree, Inc. CREE fell 12.6% to close at $98.53 after the company issued Q4 EPS guidance below analyst estimates. JP Morgan also downgraded the stock from Neutral to Underweight.
- Nemaura Medical Inc. NMRD fell 12.6% to close at $4.73.
- Smart Share Global Limited EM dropped 12.5% to settle at $8.06.
- Ribbon Communications Inc. RBBN dipped 11.9% to close at $7.17 following weak quarterly sales.
- eBay Inc. EBAY fell 10% to settle at $56.07. eBay reported upbeat Q1 earnings, but issued weak earnings guidance for the current quarter.
- Lyft, Inc. LYFT fell 9.9% to close at $57.10 on reports the US Labor Secretary said most US gig workers should be classified as employees.
- Ford Motor Company F fell 9.4% to close at $11.26 after the company reported Q1 earnings results.
- ServiceNow, Inc. NOW fell 9.4% to settle at $505.00 after the company reported Q1 earnings results.
- Peabody Energy Corporation BTU dropped 9.3% to close at $3.89 following quarterly results.
- Hologic, Inc. HOLX fell 8.5% to settle at $66.23 after the company reported worse-than-expected Q2 results and issued weak Q3 guidance.
- Teladoc Health, Inc. TDOC fell 8.3% to close at $170.86 after reporting Q1 results.
- American Shared Hospital Services AMS dropped 8.3% to close at $2.44.
- Citrix Systems, Inc. CTXS dropped 7.6% to close at $128.02 after the company reported worse-than-expected Q1 results.
- Tenaris S.A. TS fell 7.2% to close at $21.02 after the company reported Q1 results.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in